Evidence map›Paper›PMID 31835278›Full record

Trial reportHealth services research2020

Architecting Process of Care: A randomized controlled study evaluating the impact of providing nonadherence information and pharmacist assistance to physicians.

Margaret McConnell, William Rogers, Emilia Simeonova, Ira B Wilson

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Health services research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Margaret McConnellDepartment of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.ORCID 0000-0002-3437-3249
William RogersInstitute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts.
Emilia SimeonovaJohns Hopkins Carey School of Business, Baltimore, Maryland.
Ira B WilsonBrown University School of Public Health, Providence, Rhode Island.
Brown University · USHarvard Global Health Institute · USJohns Hopkins University · USTufts Medical Center · US

Funding

Translational ScienceP30AI042853 · NIAID · MIRIAM HOSPITAL · PI LARRY K BROWN · 1998 to 2026
$51.7M
Tracking and Evaluation CoreU54GM115677 · NIGMS · BROWN UNIVERSITY · PI ROUNDS, SHARON IRENE SMITH · 2016 to 2025
$45.0M
Nudging Doctors to Collaborate with Pharmacists to Improve Medication AdherenceRC4AG039072 · NIA · TUFTS MEDICAL CENTER · PI WILSON, IRA B · 2010 to 2010
$1.2M
NIAID NIH HHS P30 AI042853NIA NIH HHS RC4 AG039072NIGMS NIH HHS U54 GM115677
6 · The paper itself

Abstract

objectiveTo test the impact of connecting physicians, pharmacists, and patients to address medication nonadherence, and to compare different physician choice architectures. DATA SOURCES AND STUDY

settingThe study was conducted with 90 physicians and 2602 of their patients on medications treating chronic illness. STUDY

designIn this cluster randomized controlled trial, physicians were randomly assigned to an arm where the physician receives notification of patient nonadherence derived from real-time claims data, an arm where they receive this information and a pharmacist may contact patients either by default or by physician choice, and a control group. The primary outcome was resolving nonadherence within 30 days. We also considered physician engagement outcomes including viewing information about nonadherence and utilizing a pharmacist. DATA COLLECTION: Physician engagement was constructed from metadata from the study website; adherence outcomes were constructed from medication claims. PRINCIPAL

findingsWe see no differences between the treatment arms and control for the primary adherence outcome. The pharmacist intervention was 42 percentage points (95% CI: 28 pp-56 pp) more likely when it was triggered by default.

conclusionsAccess to a pharmacist and real-time nonadherence information did not improve patient adherence. Physician process of care was sensitive to choice architecture.

Indexed as

Drug MonitoringInterprofessional RelationsProfessional RoleAdultChronic DiseaseCommunicationFemaleHumansMaleMiddle AgedPatient CompliancePharmacistsPhysiciansUnited Statesadherencebehavioral economicschoice architecturedefaultspharmacistsphone-based interventions

Identifiers

PMID31835278
PMCPMC6981078
OpenAlexW2995398758

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.